SRT1720 HCl

Cat. No.: OB0225WX-2396

Appearance: Solid

Purity: ≥99%

Identity: Confirmed by NMR, and HPLC.

Size:

INQUIRY Datasheet MSDS

Add to basket

Product Overview

Description: SRT1720 HCl is a selective activator of SIRT1 (EC50: 0.16 microM) that exhibits over 230-fold greater potency than for the SIRT2 and SIRT3 isoforms.

Synonym: 1001645-58-4; SRT1720; SRT 1720 Hydrochloride; SRT1720 Hydrochloride; SRT 1720 (Hydrochloride); N-(2-(3-(piperazin-1-ylmethyl)imidazo[2,1-b]thiazol-6-yl)phenyl)quinoxaline-2-carboxamide hydrochloride; SRT1720 xHydrochloride; N-[2-[3-(1-Piperazinylmethyl)imidazo[2,1-b]thiazol-6-yl]phenyl]-2-quinoxalinecarboxamide hydrochloride; N-[2-[3-(piperazin-1-ylmethyl)imidazo[2,1-b][1,3]thiazol-6-yl]phenyl]quinoxaline-2-carboxamide;hydrochloride; N-(2-(3-(Piperazin-1-ylmethyl)imidazo[2,1-b]thiazol-6-yl)phenyl)quinoxaline-2-carboxamide xhydrochloride; N-{2-[3-(piperazin-1-ylmethyl)imidazo[2,1-b][1,3]thiazol-6-yl]phenyl}quinoxaline-2-carboxamide hydrochloride; N-(2-{3-[(Piperazin-1-yl)methyl]imidazo[2,1-b][1,3]thiazol-6-yl}phenyl)quinoxaline-2-carboxamide--hydrogen chloride (1/1)

CAS No.: 1001645-58-4

Compound CID: 25232708

Formula: C₂₅H₂₃N₇OS·HCl

Formula Weight: 506.02

Specification

Stability: 3 years in powder form.

Storage: Storage at -20°C.

Applications: SRT1720 HCl is used in metabolic and aging research as a potent SIRT1 activator to investigate the enhancement of mitochondrial biogenesis and the improvement of glucose homeostasis in metabolic syndrome models.